Novartis (NVS) CAR-T Therapy Kymriah Receives FDA Approval By: TalkMarkets August 31, 2017 at 15:58 PM EDT Novartis AG announced that the FDA has approved its breakthrough gene transfer treatment - CAR-T Therapy Kymriah. Read More >> Related Stocks: Aduro Biotech Gilead Sciences Novartis Ag ADR